Folium Labs
Folium Labs is a Montreal-based biotechnology company focused on developing proprietary drug and nutrient delivery platforms that enhance bioavailability and targeted delivery of active ingredients. They utilize innovative SSRM technology to improve the absorption of natural pharmaceuticals, nutraceuticals, and cannabinoids, aiming to create more effective health and wellness products.
Industries
Nr. of Employees
small (1-50)
Products
SSRM formulation platform (licensable technology)
A solid-state reactive mixing platform that produces hyaluronic acid–based, water-soluble molecular complexes intended to increase bioavailability and modify PK profiles of lipophilic active ingredients for multiple commercial formats.
Solid State Reactive Mixing
An advanced patent-pending delivery system technology invented by Folium Labs that optimizes ingredient absorption, amplifies bioavailability, and addresses poor bioavailability of lipophilic ingredients.
Solid State Reactive Mixing (SSRM)
An advanced delivery platform and manufacturing technology designed to improve bioavailability, absorption rate, and onset time for nutraceuticals, dietary supplements, pharmaceuticals, and lipophilic compounds like cannabinoids.
SSRM formulation platform (licensable technology)
A solid-state reactive mixing platform that produces hyaluronic acid–based, water-soluble molecular complexes intended to increase bioavailability and modify PK profiles of lipophilic active ingredients for multiple commercial formats.
Solid State Reactive Mixing
An advanced patent-pending delivery system technology invented by Folium Labs that optimizes ingredient absorption, amplifies bioavailability, and addresses poor bioavailability of lipophilic ingredients.
Solid State Reactive Mixing (SSRM)
An advanced delivery platform and manufacturing technology designed to improve bioavailability, absorption rate, and onset time for nutraceuticals, dietary supplements, pharmaceuticals, and lipophilic compounds like cannabinoids.
Services
Provision of the formulation platform to third-party brand owners and manufacturers via licensing or joint-venture agreements for integration into nutraceutical, cannabis, and pharmaceutical products.
Design and execution of proof-of-concept preclinical pharmacokinetic studies to assess plasma exposure (Cmax, AUC) and time-to-peak for candidate formulations versus unformulated controls.
Provision of the formulation platform to third-party brand owners and manufacturers via licensing or joint-venture agreements for integration into nutraceutical, cannabis, and pharmaceutical products.
Design and execution of proof-of-concept preclinical pharmacokinetic studies to assess plasma exposure (Cmax, AUC) and time-to-peak for candidate formulations versus unformulated controls.
Expertise Areas
- Drug delivery platform development
- Formulation development for poorly water-soluble compounds
- Hyaluronic acid–based carrier systems
- Preclinical pharmacokinetics and PK analysis
Key Technologies
- Solid-state mixing for biopolymer complexation
- Hyaluronic acid encapsulation
- Solvent-free, low-energy formulation processes
- Inclusion-complex/solid-dispersion approaches
News & Updates
Folium Labs was recognized among the Top 78 Pharmaceutical Startups in Toronto by BestStartup.ca in 2021.
An article discussing the therapeutic benefits of cannabinoids like THC and CBD, and their delivery methods.
Included in the list of top pharmaceutical startups in Toronto in 2021.
Folium Labs was recognized among the Top 78 Pharmaceutical Startups in Toronto by BestStartup.ca in 2021.
An article discussing the therapeutic benefits of cannabinoids like THC and CBD, and their delivery methods.
Included in the list of top pharmaceutical startups in Toronto in 2021.